Vaccines
Commentary
Despite ‘getting it wrong’ we must continue to do what’s right
There is no question that everyone in the United States— and most likely, the entire world—will eventually get vaccinated against COVID-19 or get...
Applied Evidence
Cervical cancer update: The latest on screening & management
Here are updated guidelines for prevention, testing, and treatment. Elimination of causative HPV continues to hold center stage in the global...
Practice Alert
2021 CDC guidelines on sexually transmitted infections
A higher dose of ceftriaxone is now recommended for gonorrhea. Doxycycline, not azithromycin, is first-line therapy for chlamydia.
From the Journals
Intent to vaccinate kids against COVID higher among vaccinated parents
“Parental vaccine hesitancy is a major issue for schools resuming in-person instruction,” according to the authors of a new paper.
Latest News
Specialists think it’s up to the PCP to recommend flu vaccines. But many patients don’t see a PCP every year
Overall, less than a third of HCPs (31%) said they recommend annual flu vaccination to all of their patients with chronic health conditions.
Conference Coverage
Single-dose HPV vaccination highly effective
Latest News
Poorly controlled asthma predicts COVID-19 hospitalization in children
Cohort study shows higher hospital admission rates that support vaccine prioritization for school-aged children.
From the Journals
HPV vaccines reduce cervical cancer rates in young females
HPV vaccination programs have been remarkably successful at reducing cervical cancer rates in young females provided they are vaccinated early...
Latest News
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
From the Journals
Big drop in U.S. cervical cancer rates, mortality in younger women
This analysis lines up with previous evidence from U.S. epidemiologic data.
Latest News
Pfizer COVID vaccine is 100% effective in adolescents: Study
The clinical trial researchers found no serious safety concerns while following patients for 6 months.